Wound News and Research

RSS

Pioneers Memorial Healthcare District purchases QuadraMed CPR EHR solution

QuadraMed® Corporation today announced that Pioneers Memorial Healthcare District in Brawley, Calif., has selected the QuadraMed CPR (QCPR™) electronic health record (EHR) solution and several other QuadraMed applications to help improve the quality of patient care, increase operational efficiencies and enhance revenues. Also included in the purchase are QuadraMed's identity management, enterprise scheduling, revenue management and nurse-staffing management solutions.

25 May 2010

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.

25 May 2010

Researchers develop new device that can change current landscape of chronic wound management

Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease.

25 May 2010

Scientists develop DNA-vaccine that restricts supply of blood to tumours

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

24 May 2010

BioLife Solutions first-quarter revenue up 36% to $513,000

BioLife Solutions, Inc., announced today that Chairman and Chief Executive Officer Mike Rice issued the following letter to shareholders providing a general corporate update.

20 May 2010

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

In this economy, allergy sufferers are looking for relief from more than sneezing, runny noses, and itchy eyes. And, according to a recent study, they can find relief for both their symptoms and their wallets, saving anywhere from $50 to $400 in out-of-pocket costs per visit if they skip the emergency room and head to urgent care and retail health clinics when they are unable to see their primary physician.

20 May 2010

New study shows preoperative statin therapy protects patients undergoing elective AAA repair

Preoperative statin therapy has a protective effect on patients undergoing elective abdominal aortic aneurysm repair that reduces risk and subsequent total hospital costs according to a new study from researchers at the East Carolina Heart Institute in Greenville, North Carolina.

20 May 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Tranzyme Pharma today announced that Philippa Charlton, MD, Tranzyme's Medical Director, and her colleagues G. Bochicchio, J.C. Pezullo, G. Kosutic, and A. Senagore, will present a poster entitled "The Prokinetic Agent TZP-101 (a Ghrelin Agonist) Accelerates GI Recovery in Partial Colectomy Patients Independently of Total Opioid Use and Type of Surgery" at the upcoming 2010 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons (ASCRS; Minneapolis, May 15-19).

17 May 2010

VNA receives grant award to enhance Wound Care Program

The Visiting Nurse Association of Greater Philadelphia has received a grant award from the First Hospital Foundation in the amount of $40,000. The grant will be used to enhance the VNA's Wound Care Program and will enable the agency to purchase digital cameras so the home visiting clinicians can document patients wound progression and improve wound care delivery.

15 May 2010

SANUWAVE Health reports $3.0 million net loss for first-quarter 2010

SANUWAVE Health, Inc.,, an emerging medical technology company focused on regenerative medicine, today reported financial results for the three months ended March 31, 2010 and provided a business update.

14 May 2010

Data from RGN-259 study published in Archives of Ophthalmology

RegeneRx Biopharmaceuticals, Inc. announced today the publication of the first human data from a case study of patients evaluated with its ophthalmic product candidate RGN-259. The data have been published in the May 2010 issue of Archives of Ophthalmology, an American Medical Association peer-reviewed journal.

14 May 2010

ULURU reports net loss of $1.3M for first-quarter 2010

ULURU Inc. today announced its financial results for the first quarter ended March 31, 2010.

14 May 2010

Derma Sciences first-quarter net sales up 23% to $12,844,382

Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months ended March 31, 2010.

14 May 2010

RBC Life Sciences first-quarter net sales increase 16% to $7.0M

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.0 million for the first quarter ended March 31, 2010, compared to net sales of $6.0 million for the same period during 2009, an increase of 16%.

12 May 2010

Pacira Pharmaceuticals receives $11.25M credit facility from GE Capital, Healthcare Financial Services

GE Capital, Healthcare Financial Services today announced it has provided an $11.25 million credit facility to Pacira Pharmaceuticals, Inc. The financing provides working capital, and facilitates advances toward regulatory approval and preparation for commercialization of Pacira's EXPAREL™ program.

12 May 2010

Aastrom Biosciences reports third quarter 2010 FY results

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported financial results for its third fiscal quarter ended March 31, 2010, and also announced progress in its late-stage clinical development programs and corporate operations.

11 May 2010

Bovie Medical first-quarter revenues decrease to $5.6M

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2010.

10 May 2010

Urgent care and retail health clinics can reduce treatment costs for allergy sufferers

10 May 2010

Findings may help develop a new class of drugs for diabetes

More than half a century after researchers identified a promising way to treat diabetes based on blocking the breakdown of insulin in the body, a research team led by a scientist at the Mayo Clinic campus in Florida have developed potent molecules that can do just that.

10 May 2010

USPTO grants patent for Quick-Med's proprietary NIMBUS polymeric antimicrobial technology

Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office. The patent for company's proprietary NIMBUS polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics.

7 May 2010

Wound News and Research

Pioneers Memorial Healthcare District purchases QuadraMed CPR EHR solution

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

Researchers develop new device that can change current landscape of chronic wound management

Scientists develop DNA-vaccine that restricts supply of blood to tumours

BioLife Solutions first-quarter revenue up 36% to $513,000

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

New study shows preoperative statin therapy protects patients undergoing elective AAA repair

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

VNA receives grant award to enhance Wound Care Program

SANUWAVE Health reports $3.0 million net loss for first-quarter 2010

Data from RGN-259 study published in Archives of Ophthalmology

ULURU reports net loss of $1.3M for first-quarter 2010

Derma Sciences first-quarter net sales up 23% to $12,844,382

RBC Life Sciences first-quarter net sales increase 16% to $7.0M

Pacira Pharmaceuticals receives $11.25M credit facility from GE Capital, Healthcare Financial Services

Aastrom Biosciences reports third quarter 2010 FY results

Bovie Medical first-quarter revenues decrease to $5.6M

Urgent care and retail health clinics can reduce treatment costs for allergy sufferers

Findings may help develop a new class of drugs for diabetes

USPTO grants patent for Quick-Med's proprietary NIMBUS polymeric antimicrobial technology

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News